Who must sign the list?

Facility policy typically requires approval by pharmacy leadership and the safety or pharmacy committee. Signatures provide accountability for clinical review and protocol assignment.

Is electronic signature acceptable?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA in most states when intent, consent, attribution, and retention are demonstrated.

Not usually. Internal policy approvals rarely require notarization; use notarization only if a downstream legal process or state rule specifically requires it.

How often should the list be reviewed?

Perform formal reviews at least annually and immediately after new formulary additions, safety alerts, or significant changes in preparation/administration methods.

How should I distribute changes?

Publish a controlled version to the designated repository, push alerts into the EHR where relevant, and notify affected units with a summary of changes and effective date.

How long must approvals be retained?

Retain signed approvals and version history per HIPAA and occupational record guidance—typically a minimum of 3–6 years; extend retention where exposure or state rules require longer.

Electronic Signature
Templates
Healthcare
Healthcare Hazardous Drug List

Healthcare Hazardous Drug List

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Hazardous Drug List

Facility Name: Department:

Scope and Purpose

This hazardous drug list identifies agents that require special handling, personal protective equipment, compounding, storage, administration, and disposal controls within the facility. The list is maintained to reduce occupational exposures, promote patient safety, and ensure regulatory and professional standard compliance. All staff responsible for handling, transporting, compounding, administering, or disposing of listed agents must adhere to applicable facility policies and written procedures.

Administrative Information

List Owner Owner Title Owner Contact (phone or pager) Effective Date Next Scheduled Review

Hazardous Drug Entries

Enter each hazardous drug on its own row. Include handling precautions and disposal/storage instructions specific to the facility practice setting.

Drug Entry 1 — Drug Name

Classification / Hazard Category

Dosage Form & Strength

Route of Administration

Manufacturer

Primary Clinical Indication Handling Precautions

PPE Required

Compounding

Yes No

Hazardous in Bulk

Yes No

Storage & Disposal Instructions

Date Added

Date Removed (if applicable)

Drug Entry 2 — Drug Name

Classification / Hazard Category

Dosage Form & Strength

Route of Administration

Manufacturer

Primary Clinical Indication Handling Precautions

PPE Required

Compounding

Yes No

Hazardous in Bulk

Yes No

Storage & Disposal Instructions

Date Added

Date Removed (if applicable)

Drug Entry 3 — Drug Name Classification / Dosage Form / Route / Manufacturer Handling Precautions Storage & Disposal Instructions

Drug Entry 4 — Drug Name Classification / Dosage Form / Route / Manufacturer Handling Precautions Storage & Disposal Instructions

Drug Entry 5 — Drug Name Classification / Dosage Form / Route / Manufacturer Handling Precautions Storage & Disposal Instructions

Drug Entry 6 — Drug Name Classification / Dosage Form / Route / Manufacturer Handling Precautions Storage & Disposal Instructions

Administrative Clauses and Certification

This list is the official facility hazardous drug roster for the department(s) identified above. The facility requires that: (1) personnel handling listed agents receive appropriate education and documented competency for required procedures and personal protective equipment; (2) the pharmacy and clinical leaders coordinate updates to this list when new agents are introduced or classifications change; and (3) the list and associated handling procedures are made available to all affected personnel at least as frequently as the scheduled review. The facility retains the right to add or remove agents from the list without prior notice when required for safety.

Comments or Special Instructions Acknowledgment

By signing below, the authorized representative certifies that the information provided in this Healthcare Hazardous Drug List is accurate and complete to the best of their knowledge as of the date signed, and that all necessary dissemination and training will be performed for affected staff.

Authorized Representative:

Title:

Signature:

Date:

What the Healthcare Hazardous Drug List Is and why it exists

A Healthcare Hazardous Drug List is a facility-maintained inventory of pharmaceuticals classified as hazardous for handling, preparation, administration, transport, or disposal. The list typically consolidates drugs identified by regulators or safety organizations, local pharmacy committees, and institutional risk assessments to support safe handling protocols, appropriate engineering controls, personal protective equipment selection, spill response, and employee training.

Why maintaining an accurate hazardous drug list matters

A current list reduces exposure risk for staff and patients, supports regulatory compliance, and drives consistent pharmacy and clinical procedures across settings.

Who prepares and relies on the hazardous drug list

A small set of clinical and safety roles typically owns and uses the list within a healthcare facility.

Pharmacy directors and clinical pharmacists responsible for formulary decisions and compounding controls.
Occupational health and safety officers who evaluate exposure risk and set PPE and engineering controls.
Nursing leadership and unit managers who implement bedside handling, administration, and spill procedures.

Effective lists are maintained collaboratively and reviewed at regular intervals to reflect new drugs, updated toxicity data, and changes to preparation or administration methods.

Core components of a professional hazardous drug list

A complete list combines clear identifiers with handling guidance and links to supporting procedures so clinical staff can act quickly and consistently.

Drug Identifier

Active ingredient and trade name, strength, and common formulations so staff recognize the product on receipt and during preparation.

NIOSH Category

Classification or reference to NIOSH or other toxicity guidance to indicate the hazardous class and applicable control measures.

Formulation Details

Dosage form and concentration (e.g., vial 10 mg/mL, powder, IV bag) that determine manipulation and containment methods.

Handling Precautions

Required PPE, engineering controls (e.g., biological safety cabinet), and spill response steps tied to each drug entry.

Storage & Disposal

Recommended storage conditions, segregation needs, and disposal pathway including hazardous waste classification.

Last Review

Date of clinical review and approval plus the responsible committee or individual for change control.

Essential administrative metadata to keep with the list

Maintainer: Name of responsible department

Approval: Approving committee or officer

Version: Document version identifier

Review Date: Next scheduled review date

Distribution: Who receives the list

Storage: Record location and access controls

Step-by-step: creating or updating a hazardous drug list

Use a repeatable sequence to add, review, and approve drugs so updates are timely and defensible.

01

Identify Candidates: Gather drugs from formulary changes, NIOSH lists, and safety alerts.
02

Assess Hazards: Document toxicology, routes of exposure, and concentration-based risks.
03

Draft Controls: Specify PPE, engineering, and disposal linked to each entry.
04

Review & Approve: Pharmacy committee signs off and publishes the updated list.

Configuring an online workflow for list maintenance

A simple digital workflow enforces review steps, records approvals, and notifies stakeholders automatically.

Field	Configuration
Submission Form	Enable a fillable form for nominations and required fields.
Automated Routing	Route submissions to pharmacy, occupational health, then committee.
Approval Step	Require explicit electronic signature and date stamp for approval.
Audit Trail	Capture user, timestamp, and change history for each edit.

Where to file and who receives the updated list

Establish a single authoritative location and a standard distribution path so staff access the current list without confusion.

Pharmacy Repository: Primary storage in the pharmacy management system or intranet document library.
Electronic Health Record: Push relevant entries or alerts into the EHR medication administration modules.
Clinical Units: Notify nursing managers and unit educators of changes via scheduled distribution.
Safety & Compliance: Retain signed approvals in risk management or compliance records.

Technical considerations for digital lists and e-submission

Choose tools that preserve audit trails, support secure access, and interoperate with clinical systems.

Document Formats: PDF, DOCX, or structured database exports supported
Integrations: Connectors for EHR, Google Workspace, Microsoft 365, or document repositories
Security Controls: Role-based access and encryption at rest and in transit

Ensure chosen platforms allow reproducible records, support HIPAA protections for associated PHI, and retain an immutable audit trail for reviews and inspections.

Typical eSignature vendor comparison for maintaining and approving the list

Basic pricing and capability differences across common eSignature providers. signNow is listed first per comparison conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Potential legal and safety consequences of an incomplete or inaccurate list

Regulatory Citation: OSHA or state agency enforcement

Patient Harm: Increased risk of dosing or administration errors

Staff Exposure: Occupational illness and workers' comp claims

Liability: Civil suits from exposure incidents

HIPAA Risk: Improper lists tied to PHI disclosures

Operational Disruption: Supply and compounding workflow errors

Common pitfalls when preparing the Healthcare Hazardous Drug List

Using inconsistent drug names across sources, which creates duplicate or missing entries and confusion at the point of care.
Failing to tie handling instructions to specific formulations, leading to inappropriate PPE or engineering controls being applied.
Not documenting review dates and approvers, which undermines traceability during audits or exposure investigations.
Distributing unversioned copies across units so staff reference outdated procedures and policies.

Practical tips for accurate and efficient list management

Apply consistent governance, automate notifications, and use structured formats to minimize errors and speed adoption.

Centralize ownership and review

Assign a single department or committee to approve changes and define a published review cadence to ensure the list remains authoritative.

Use structured, searchable fields

Maintain form fields for NIOSH category, formulation, PPE, and review date to enable fast lookup and integration with EHR or inventory systems.

Record audit trails and signatures

Capture who approved each change and when; retain digital signatures and timestamps to support inspections and incident response.

Train clinicians on updates

Communicate changes with unit-level education and require acknowledgment to confirm adoption of new handling procedures.

Frequently asked questions about the Healthcare Hazardous Drug List

Answers to common operational and compliance questions encountered when creating, approving, and distributing the list.

Need help? Contact support

Who must sign the list?
Facility policy typically requires approval by pharmacy leadership and the safety or pharmacy committee. Signatures provide accountability for clinical review and protocol assignment.
Is electronic signature acceptable?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA in most states when intent, consent, attribution, and retention are demonstrated.
Do I need a notary?
Not usually. Internal policy approvals rarely require notarization; use notarization only if a downstream legal process or state rule specifically requires it.
How often should the list be reviewed?
Perform formal reviews at least annually and immediately after new formulary additions, safety alerts, or significant changes in preparation/administration methods.
How should I distribute changes?
Publish a controlled version to the designated repository, push alerts into the EHR where relevant, and notify affected units with a summary of changes and effective date.
How long must approvals be retained?
Retain signed approvals and version history per HIPAA and occupational record guidance—typically a minimum of 3–6 years; extend retention where exposure or state rules require longer.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now